Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)

This study has been terminated.
Information provided by (Responsible Party):
UCB Pharma Identifier:
First received: June 10, 2005
Last updated: March 30, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2007
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)